Dihydralazine: Difference between revisions

Jump to navigation Jump to search
m (Protected "Dihydralazine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{drugbox |
{{Drugbox
| IUPAC_name = (4-Hydrazinylphthalazin-1-yl)hydrazine
| Verifiedfields = changed
| image = Dihydralazine structure.svg
| Watchedfields = changed
| verifiedrevid = 460786592
| IUPAC_name = 4-hydrazinyl-1-hydrazinylidene-1,2-dihydrophthalazine
| image = Dihydralazine.png
| image2 = Dihydralazine_ball-and-stick.png
 
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|international|dihydralazine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_UK = <!-- GSL        / P      / POM / CD -->
| legal_US = <!-- OTC                  / Rx-only  -->
| legal_status = 
| routes_of_administration = 
 
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
 
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 484-23-1
| CAS_number = 484-23-1
| ATC_prefix = C02
| ATC_prefix = C02
| ATC_suffix = DB01
| ATC_suffix = DB01
| PubChem = 10230
| PubChem = 10230
| DrugBank =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| C=8|H=10|N=6
| DrugBank =
| molecular_weight = 190.205
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| bioavailability =  
| ChemSpiderID = 9813
| protein_bound =  
| UNII_Ref = {{fdacite|correct|FDA}}
| metabolism =  
| UNII = PCU411F5L6
| elimination_half-life =  
| KEGG_Ref = {{keggcite|correct|kegg}}
| excretion =  
| KEGG = D07170
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| pregnancy_US = <!-- A / B            / C / D / X -->
| ChEMBL = 35505
| pregnancy_category =
 
| legal_AU =     <!-- Unscheduled / S2 / S3 / S4  / S8 -->
<!--Chemical data-->
| legal_UK =      <!-- GSL        / P      / POM / CD -->
| C=8 | H=10 | N=6
| legal_US =      <!-- OTC                  / Rx-only  -->
| molecular_weight = 190.205 g/mol
| legal_status =  
| smiles = n2nc(c1ccccc1c2NN)NN
| routes_of_administration =  
| InChI = 1/C8H10N6/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7/h1-4H,9-10H2,(H,11,13)(H,12,14)
| InChIKey = VQKLRVZQQYVIJW-UHFFFAOYAA
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H10N6/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7/h1-4H,9-10H2,(H,11,13)(H,12,14)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VQKLRVZQQYVIJW-UHFFFAOYSA-N
}}
}}
              __NOTOC__
{{SI}}
{{CMG}}
==Overview==


'''Dihydralazine''' is a [[pyridazine]] [[antiadrenergic]] agent.
'''Dihydralazine''' is a drug with [[antihypertensive]] properties.<ref>{{cite pmid|6477782}}</ref> It belongs to the [[hydrazinophthalazine]] [[chemical class]].<ref name=Bourreli1988>{{cite pmid|3383316}}</ref> It has very similar effects to [[hydralazine]].<ref name=Bourreli1988/>
==See also==
*[[Hydralazine]]


==References==
{{Reflist|2}}


{{pharma-stub}}


[[Category:Drugs]]
[[Category:Hydrazines]]
[[Category:Hydrazines]]
 
[[Category:Drug]]
[[de:Dihydralazin]]
[[Category:Antihypertensive agents]]

Latest revision as of 14:17, 10 April 2015

Dihydralazine
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC8H10N6
Molar mass190.205 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Dihydralazine

Articles

Most recent articles on Dihydralazine

Most cited articles on Dihydralazine

Review articles on Dihydralazine

Articles on Dihydralazine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dihydralazine

Images of Dihydralazine

Photos of Dihydralazine

Podcasts & MP3s on Dihydralazine

Videos on Dihydralazine

Evidence Based Medicine

Cochrane Collaboration on Dihydralazine

Bandolier on Dihydralazine

TRIP on Dihydralazine

Clinical Trials

Ongoing Trials on Dihydralazine at Clinical Trials.gov

Trial results on Dihydralazine

Clinical Trials on Dihydralazine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dihydralazine

NICE Guidance on Dihydralazine

NHS PRODIGY Guidance

FDA on Dihydralazine

CDC on Dihydralazine

Books

Books on Dihydralazine

News

Dihydralazine in the news

Be alerted to news on Dihydralazine

News trends on Dihydralazine

Commentary

Blogs on Dihydralazine

Definitions

Definitions of Dihydralazine

Patient Resources / Community

Patient resources on Dihydralazine

Discussion groups on Dihydralazine

Patient Handouts on Dihydralazine

Directions to Hospitals Treating Dihydralazine

Risk calculators and risk factors for Dihydralazine

Healthcare Provider Resources

Symptoms of Dihydralazine

Causes & Risk Factors for Dihydralazine

Diagnostic studies for Dihydralazine

Treatment of Dihydralazine

Continuing Medical Education (CME)

CME Programs on Dihydralazine

International

Dihydralazine en Espanol

Dihydralazine en Francais

Business

Dihydralazine in the Marketplace

Patents on Dihydralazine

Experimental / Informatics

List of terms related to Dihydralazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dihydralazine is a drug with antihypertensive properties.[1] It belongs to the hydrazinophthalazine chemical class.[2] It has very similar effects to hydralazine.[2]

See also

References

  1. PMID 6477782 (PMID 6477782)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
  2. 2.0 2.1 PMID 3383316 (PMID 3383316)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand